Services Provided  
  Clinical Services  
  Wellness Center  
  Immunization  
  Insurance  
  Women's Health  
  Pharmacy  
  Classes/Workshops  
  General Information  
     Mission
   Student Health Fee
   Health Policies
   Location/Maps
   Parking
   FAQ
 
  Health Topics  
  Staff  
  Reports/Publications  
  Employee Access  
  Current Location:  Home > General Information > FAQ
 
  Frequently Asked Questions  
 
 

Meningococcal Meningitis
Frequently Asked Questions

The DISEASE:

  • What is meningococcal meningitis?
    Meningococcal meningitis is a bacterial infection that causes inflammation of the membranes surrounding the brain and spinal cord. It is caused by the bacterium Neisseria meningititidis, also known as meningococcus.
  • What are the symptoms?
    Symptoms include fever, severe headache, stiff neck, rash, nausea, vomiting, and lethargy. The infection can lead to permanent disabilities, such as hearing loss and brain damage. Despite antibiotic treatment, 10% of people with meningococcal meningitis die each year from the disease.
  • What is meningococcemia?
    Sometimes the meningococcal bacteria can infect the bloodstream. This infection is termed meningococcemia. It can lead to kidney and heart failure, and like meningococcal meningitis, can result in severe disability and death. 20% of patients with meningococcemia die from the infection.
  • How is the disease spread?
    The infection is spread by direct contact with infected individuals (for example, sharing a glass or cigarette, or kissing) or through the air via droplets of respiratory secretions (for example, coughing or sneezing). 
  • How common is meningococcal disease?
    Neisseria meningitis is the second most common cause of bacterial meningitis in the United States, responsible for 3,000-4,000 cases each year. While meningococcal disease overall remains relatively rare, the number of outbreaks has been on the rise in recent years. Whereas there were only 13 outbreaks during the 12 year period from 1980 to 1991, at least 33 outbreaks hit in just the five years between 1992 and 1996, according to the Centers for Disease Control and Prevention (CDC).
  • Why are college students at great risk for meningococcal disease than the general population?
    While the reasons are not yet fully understood, studies from previous college outbreaks suggest that college students are more susceptible because they live and work in close proximity to each other in residence halls and classrooms. Behavioral and social aspects of college life appear to be risk factors as well, such as smoking, alcohol consumption, risky sexual behaviors, and kissing, all increasing the chance that one will contract meningitis from an infected individual.

The VACCINE:

  • Is there any way for college students to protect themselves against the threat of meningococcal disease?
    Yes. Safe, effective vaccination can provide protection against four out of the five strains of the disease (serogroups A, C, Y, and W-135, there is currently no vaccine for serogroup B). These four strains cause nearly 70% of meningococcal meningitis cases on college campuses.
  • Why should college students consider preventive vaccination with the meningococcal vaccine?
    In the past, vaccination usually has been delayed until an outbreak of meningitis occurs. The problem with this strategy is that outbreaks, while rare, are clustered in time, and that the onset of these flu-like symptoms is extremely rapid. Often, one does not have characteristic symptoms of meningitis until it is too late for the vaccine to provide real protection. The American College Health Association (ACHA) and the Advisory Committee on Immunization Practices (ACIP) have recently recommended that all college students consider vaccination against meningitis. According to the ACIP research, the incidence of meningitis is "highest among freshman dormitory residents".
  • What are the side effects of the vaccine? How safe is it?
    The meningococcal vaccine has an excellent safety profile. Side effects are mild and infrequent, consisting primarily of redness and swelling at the site of injection lasting up to two days. Meningococcal immunization should be deferred during any acute illness. The vaccine should not be administered to women who are pregnant or individuals sensitive to thimerosal or other components of the vaccine.
  • How effective is the vaccine and how long does it last?
    The vaccine has been shown to create protective levels of antibodies against the four most common strains of meningococcus in over 90% of adults studied. As with any vaccine, meningococcal vaccination may not protect 100% of susceptible individuals. Protection from the vaccine lasts for at least 3-5 years.
  • Can college students do anything else to reduce the risk of contracting meningococcal disease?
    Maximize your body’s own immune system. Eat a balanced diet, and get adequate sleep and exercise. Avoid cigarettes, cigars, recreational drugs, and excessive use of alcohol. In particular, do not share drinks.
  • Will my insurance company reimburse for this vaccine?
    Many insurance companies do not currently reimburse the cost of the meningitis vaccine. The reason for this is that the recommendation for meningitis vaccination is a fairly recent one, and many insurance companies are not aware of the increased risk which college students face. It is best to check with your individual insurance carrier.

 

 

 


Copyright © 2006, Florida International University, Miami, FL 33199